首页 | 本学科首页   官方微博 | 高级检索  
     

门冬胰岛素注射液30强化治疗初诊2型糖尿病临床观察
引用本文:丁琼. 门冬胰岛素注射液30强化治疗初诊2型糖尿病临床观察[J]. 吉林医学, 2012, 0(1): 33-34
作者姓名:丁琼
作者单位:贵州省毕节地区医院
摘    要:目的:对新诊断的2型糖尿病患者应用门冬胰岛素注射液(诺和锐)30强化治疗的疗效进行观察。方法:对新诊断的2型糖尿病患者使用门冬胰岛素注射液(诺和锐)30进行皮下注射,3次/d,2周后改为预混胰岛素皮下注射,2次/d。结果:门冬胰岛素注射液(诺和锐)30强化治疗EPG达标时间(5±2)d,2HPG达标时间(8±3)d。结论:门冬胰岛素注射液(诺和锐)30强化治疗能更快、更稳地降低血糖。

关 键 词:2型糖尿病  门冬胰岛素注射液30  强化治疗

Intensive treatment of preliminary diagnosed type 2 diabetes with insulin aspart injection 30
DING Qiong. Intensive treatment of preliminary diagnosed type 2 diabetes with insulin aspart injection 30[J]. Jilin Medical Journal, 2012, 0(1): 33-34
Authors:DING Qiong
Affiliation:DING Qiong(Bijie District Hospital,Bijie 551700,China)
Abstract:Objective To observe the effect of intensive treatment of preliminary diagnosed type 2 diabetes with insulin aspart injection 30.Method The preliminary diagnosed type 2 diabetes patients were treated with subcutaneous injection of insulin aspart injection 30(tid),and changed to premixed insulin subcutaneous injection(bid) 2 weeks later.Results The FPG standard time was(5±2) d,and 2 HPG standard time was(8±3) d after intensive treatment with insulin aspart injection 30.Conclusion The intensive treatment with insulin aspart injection 30 can lower the blood glucose more quickly and stable.
Keywords:Type 2 diabetes  Insulin aspart injection 30  Intensive treatment
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号